Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-07-16

Encompass Health (EHC)

Fiscal year 2025 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$10,297,258
Mark Tarr total, FY2025
47th
CEO pay percentile vs peers
203:1
CEO-to-median pay ratio
96.52%
Say-on-pay support, latest vote
Companies that benchmark against EHC
13 companies name EHC as a compensation peer

Each company listed discloses EHC in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named EHC in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Mark Tarr$1,100,000$0$5,285,381$1,165,376$2,581,525$0$164,976$10,297,258
President and Chief Executive Officer
Douglas Coltharp750,00001,982,088437,0071,303,800048,2764,521,171
Executive Vice President and Chief Financial Officer
Patrick Tuer550,00001,425,0950786,861081,4322,843,388
Executive Vice President and Chief Operating Officer
Patrick Darby625,0000963,693212,463869,200011,7502,682,106
Executive Vice President, General Counsel and Secretary
Elissa Charbonneau435,0000518,4520453,722037,4091,444,583
Chief Medical Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY20242025
Mark Tarr$10,297,258$9,301,929$8,836,376+995,329
Douglas Coltharp4,521,1713,868,7365,750,370+652,435
Patrick Tuer2,843,388
Patrick Darby2,682,1062,558,9943,167,110+123,112
Elissa Charbonneau1,444,5831,291,5871,298,212+152,996

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Joan E. HermanDirector2026-04-15A85$0$0CommonForm 4 ↗
Christopher R. ReidyDirector2026-04-15A1900CommonForm 4 ↗
Christopher R. ReidyDirector2026-04-15A33410635,564CommonForm 4 ↗
Terrance WilliamsDirector2026-04-15A2700CommonForm 4 ↗
Greg D. CarmichaelDirector2026-04-15A2700CommonForm 4 ↗
Edward M. Christie IIIDirector2026-04-15A900CommonForm 4 ↗
Kevin J. O'ConnorDirector2026-04-15A1700CommonForm 4 ↗
Nancy M. SchlichtingDirector2026-04-15A3900CommonForm 4 ↗
Cain A. HayesDirector2026-04-15A100CommonForm 4 ↗
Edward M. Christie IIIDirector2026-04-15A26110627,710CommonForm 4 ↗
Leslye G. KatzDirector2026-04-15A8500CommonForm 4 ↗
Christopher R. ReidyDirector2026-05-07A1,63400CommonForm 4 ↗
Cain A. HayesDirector2026-05-07A1,63400CommonForm 4 ↗
Greg D. CarmichaelDirector2026-05-07A1,63400CommonForm 4 ↗
Leslye G. KatzDirector2026-05-07A1,63400CommonForm 4 ↗
Joan E. HermanDirector2026-05-07A1,63400CommonForm 4 ↗
Nancy M. SchlichtingDirector2026-05-07A1,63400CommonForm 4 ↗
Kevin J. O'ConnorDirector2026-05-07A1,63400CommonForm 4 ↗
Edward M. Christie IIIDirector2026-05-07A1,63400CommonForm 4 ↗
Terrance WilliamsDirector2026-05-07A1,63400CommonForm 4 ↗
Patrick TuerEVP, Chief Operating Officer2026-05-11D68210571,310CommonForm 4 ↗
Douglas ColtharpEVP & Chief Financial Officer2026-05-15D1107107CommonForm 4 ↗
Douglas ColtharpEVP & Chief Financial Officer2026-05-15D27,69400Derivative, Class A CommonForm 4 ↗
Douglas ColtharpEVP & Chief Financial Officer2026-05-15D27,6931072,958,443CommonForm 4 ↗
Douglas ColtharpEVP & Chief Financial Officer2026-05-15A27,69433912,240CommonForm 4 ↗
Christopher R. ReidyDirector2026-07-15A31911235,856CommonForm 4 ↗
Joan E. HermanDirector2026-07-15A8500CommonForm 4 ↗
Leslye G. KatzDirector2026-07-15A8500CommonForm 4 ↗
Cain A. HayesDirector2026-07-15A400CommonForm 4 ↗
Greg D. CarmichaelDirector2026-07-15A2900CommonForm 4 ↗
Edward M. Christie IIIDirector2026-07-15A1100CommonForm 4 ↗
Edward M. Christie IIIDirector2026-07-15A24811227,883CommonForm 4 ↗
Terrance WilliamsDirector2026-07-15A2900CommonForm 4 ↗
Nancy M. SchlichtingDirector2026-07-15A4000CommonForm 4 ↗
Kevin J. O'ConnorDirector2026-07-15A1900CommonForm 4 ↗
Christopher R. ReidyDirector2026-07-15A2100CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Patrick DarbyOTHER2025-03-0445$212,463
Patrick TuerRSU2025-05-015,984693,785
Douglas ColtharpOTHER2025-03-0445437,007
Elissa CharbonneauPSU2025-02-202201,939193,687
Elissa CharbonneauPSU2025-02-201,0902,9085,816324,765
Mark TarrPSU2025-02-2013,67236,45772,9144,071,518
Mark TarrOPTION2025-03-0433,0861,165,376
Patrick TuerPSU2025-02-202202,735273,199
Patrick DarbyPSU2025-02-202,4936,64713,294742,337
Douglas ColtharpPSU2025-02-202204,557455,199
Patrick TuerPSU2025-02-201,5384,1028,204458,111
Douglas ColtharpPSU2025-02-205,12713,67227,3441,526,889
Patrick DarbyPSU2025-02-202202,216221,356
Mark TarrPSU2025-02-2022012,1521,213,863
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Patrick Darby$0$963,693$0100.0%
Patrick Tuer693,785731,310051.3%
Douglas Coltharp01,982,0880100.0%
Elissa Charbonneau0518,4520100.0%
Mark Tarr05,285,3811,165,37681.9%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Patrick DarbyPSU13,294$1,411,025
Patrick TuerPSU8,204870,772
Elissa CharbonneauRSU991105,185
Douglas ColtharpPSU37,5883,989,591
Patrick DarbyRSU985104,548
Douglas ColtharpPSU31,4863,341,924
Elissa CharbonneauPSU8,914946,132
Douglas ColtharpRSU3,499371,384
Patrick DarbyRSU2,216235,206
Patrick TuerPSU10,2541,088,360
Patrick TuerRSU5,984635,142
Patrick TuerRSU2,735290,293
Patrick TuerRSU1,140121,000
PriceOption2,973,09060.27
Douglas ColtharpRSU31,3213,324,411
Douglas ColtharpPSU27,3442,902,292
Patrick DarbyPSU17,7201,880,800
Mark TarrRSU9,8601,046,540
Elissa CharbonneauPSU7,468792,654
Mark TarrOption16,50056.21
Mark TarrOption33,08698.45
Patrick DarbyOption6,03298.45
PriceOption2,957,67260.27
Douglas ColtharpOption9,82474.2
Douglas ColtharpOption6,14456.21
Patrick DarbyOption5,26374.2
Patrick DarbyOption2,89756.21
Douglas ColtharpRSU2,089221,726
Elissa CharbonneauRSU1,939205,806
Patrick DarbyRSU1,875199,013
Mark TarrOption27,68374.2
Patrick TuerPSU11,0401,171,786
Mark TarrPSU100,94610,714,409
Mark TarrPSU88,7309,417,802
Mark TarrPSU72,9147,739,092
Patrick DarbyPSU16,8681,790,370
Patrick DarbyRSU14,7741,568,112
Mark TarrRSU12,1521,289,813
Elissa CharbonneauPSU5,816617,310
Mark TarrRSU5,609595,339
Douglas ColtharpRSU4,557483,680
Patrick TuerRSU2,454260,467
Elissa CharbonneauRSU1,660176,192
Douglas ColtharpOption12,40798.45
05

Incentive-plan design — the Compensation Discussion & Analysis

Provide a competitive rewards program for our senior management that aligns management's interests with those of our long-term stockholders. Correlate compensation with corporate, regional and business unit outcomes by recognizing performance with appropriate levels and forms of awards

CEO STI target (% of salary)135%
CEO LTI target (% of salary)
Independent consultantPay Governance
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-05-0783,410,8293,006,776102,63696.52%Passed
20252025-05-0187,426,4502,187,504342,77997.56%Passed
20242024-05-0287,432,8471,824,905859,43897.02%Passed
20232023-05-0482,107,7985,282,269136,69593.81%Passed
20222022-05-0583,468,0114,073,77066,35295.27%Passed
20212021-05-0681,575,2573,257,38548,89696.1%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-05-0796.52%a
20252025-05-0197.56%b
20242024-05-0297.02%c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Approved under the standard stated in the filing — “Under applicable Delaware law, in determining whether any stockholder proposal has received the requisite number of affirmative votes, abstentions will have the same effect as a vote against any stockholder proposal.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)203 : 1
CEO total compensation$10,297,258
Median employee compensation$50,647
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Greg D. CarmichaelIndependent · Board Chair · Compensation and Human Capital$260,000$165,099$0$0$10,112$435,211
Leslye G. KatzIndependent · Audit · Nominating/Corporate Governance (Chair)130,000165,0990032,510327,609
Christopher R. ReidyIndependent · Audit (Chair) · Nominating/Corporate Governance140,000165,099006,834311,933
Nancy M. SchlichtingIndependent · Compensation and Human Capital · Compliance/Quality of Care (Chair)130,000165,0990014,474309,573
Joan E. HermanIndependent · Compensation and Human Capital · Compliance/Quality of Care110,000165,0990032,510307,609
Kevin J. O'ConnorIndependent · Compensation and Human Capital (Chair) · Compliance/Quality of Care115,000165,099005,981286,080
Terrance WilliamsIndependent · Audit110,000165,0990010,112285,211
Edward M. Christie IIIIndependent · Audit110,000165,099002,797277,896
Patricia A. MarylandIndependent · Departed during FY97,500165,099007,268269,867
Cain A. HayesIndependent · Compensation and Human Capital · Compliance/Quality of Care · Partial-year service · Newly elected000000
Mark J. TarrEmployee director00000
09

Board fee structure and ownership guideline

Annual cash retainer$110,000
Annual equity retainer$165,000
Per board meeting fee
Committee chair fees (audit / comp / nom-gov)30,000 / 20,000 / 20,000
Stock ownership guideline$550,000
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$1,202,500
Equity awards (grant-date value)$1,485,891
All other compensation$122,598
Total cost of the board$2,810,989

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Encompass Health names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Encompass Health.

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Labcorp Holdings2025Adam Schechter$1,435,000$11,400,463$2,754,582$2,062,095$18,339,913
2DaVita2025Javier Rodriguez1,500,00011,442,4812,699,9822,089,49118,210,597
3Universal Health Services2025Marc Miller1,430,7699,999,90404,292,30716,148,937
4Quest Diagnostics2025James Davis1,250,0008,762,8612,999,8732,205,84415,498,479
5R1 RCM2023Lee Rivas900,00012,240,02101,015,20014,159,376
6Ensign Group2025Barry Port549,2642,912,355010,317,24713,804,700
7Chemed2025Kevin McNamara1,862,8372,883,5535,036,0211,486,97612,904,720
8Alignment Healthcare2025John Kao833,6548,500,01401,944,49511,278,583
9AMN Healthcare2025Cary Grace1,060,0008,363,11701,146,12510,669,780
10Encompass Health2025Mark Tarr1,100,0005,285,3811,165,3762,581,52510,297,258
11Option Care Health2025John Rademacher1,000,0006,500,05001,665,0009,266,330
12Acadia Healthcare2025Christopher Hunter1,061,0005,712,01201,135,2707,909,463
13Surgery Partners2025J. Eric Evans1,050,0005,000,000006,083,862
14Agilon health2025Jeffrey Schwaneke625,0002,950,0031,750,000271,8755,610,878
15Brookdale Senior Living2025Nikolas Stengle229,3104,283,9680403,5715,307,655
16Select Medical Holdings2025Thomas Mullin618,0001,425,0000939,3603,042,527
Amedisysnot in coverage universe
PACS Groupnot in coverage universe
BrightSpring Health Servicesnot in coverage universe
Community Health Systemsnot in coverage universe
ModivCarenot in coverage universe

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Encompass Health173.8%PSU 60 · RSU 20 · Options 20NoPay Governance
Acadia Healthcare85.6%PSU 50 · RSU 50NoWillis Towers Watson
Agilon health58%RSU 50 · Options 50NoSemler Brossy
Alignment Healthcare200%RSU 50 · PSU 50NoFW Cook
Amedisysnot disclosednot disclosednot disclosednot disclosed
AMN Healthcare87%PSU 65 · RSU 35Yes — Relative TSRFW Cook
BrightSpring Health Servicesnot disclosednot disclosednot disclosednot disclosed
Brookdale Senior Living125.7%PSU 60 · RSU 40NoF.W. Cook & Co., Inc.
Chemed60.4%not disclosedYes — 3-Year Relative TSRCompensation Strategies, Inc.
Community Health Systemsnot disclosednot disclosednot disclosednot disclosed
DaVita93%PSU 60 · RSU 20 · Options 20Yes — Relative TSR v. S&P Health Care Services Select Industry IndexCompensia
Ensign Groupnot disclosednot disclosednot disclosedWillis Towers Watson
Labcorp Holdings95.8%PSU 60 · RSU 20 · Options 20Yes — RELATIVE TSR MODIFIERFW Cook
ModivCarenot disclosednot disclosednot disclosednot disclosed
Option Care Health111%PSU 60 · RSU 40NoPearl Meyer
PACS Groupnot disclosednot disclosednot disclosednot disclosed
Quest Diagnosticsnot disclosednot disclosednot disclosedSemler Brossy
R1 RCM94%PSU 75 · RSU 25NoSullivanCotter
Select Medical Holdings190%RSU 100not disclosednot disclosed
Surgery Partnersnot disclosedPSU 60 · Restricted Stock 40NoFrederic W. Cook & Co., Inc. (FW Cook)
Universal Health Services200%RSU 50 · PSU 50NoFW Cook

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Mark TarrDEF 14A2026-04-070000785161-26-000105Section “Summary Compensation Table” · page 49. As printed: 10,297,258. Filing ↗machine: r2 · c48 · span 734470–734480
2Section 01, Douglas ColtharpDEF 14A2026-04-070000785161-26-000105Section “Summary Compensation Table” · page 49. As printed: 4,521,171. Filing ↗machine: r8 · c48 · span 749784–749793
3Section 01, Patrick TuerDEF 14A2026-04-070000785161-26-000105Section “Summary Compensation Table” · page 49. As printed: 2,843,388. Filing ↗machine: r5 · c48 · span 744804–744813
4Section 01, Patrick DarbyDEF 14A2026-04-070000785161-26-000105Section “Summary Compensation Table” · page 49. As printed: 2,682,106. Filing ↗machine: r11 · c48 · span 759299–759308
5Section 01, Elissa CharbonneauDEF 14A2026-04-070000785161-26-000105Section “Summary Compensation Table” · page 49. As printed: 1,444,583. Filing ↗machine: r14 · c48 · span 768121–768130
6Section 03, Patrick Darby OTHERDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t65 · r37 · c7 · span 1036109–1036111
7Section 03, Patrick Tuer RSUDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t65 · r16 · c12 · span 986149–986154
8Section 03, Douglas Coltharp OTHERDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t65 · r27 · c7 · span 1012654–1012656
9Section 03, Elissa Charbonneau PSUDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t65 · r41 · c12 · span 1045105–1045110
10Section 03, Elissa Charbonneau PSUDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t60 · r12 · c7 · span 796786–796793
11Section 03, Mark Tarr PSUDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t60 · r2 · c7 · span 781184–781193
12Section 03, Mark Tarr OPTIONDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t65 · r11 · c4 · span 974330–974336
13Section 03, Patrick Tuer PSUDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t61 · r3 · c5 · span 807288–807290
14Section 03, Patrick Darby PSUDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t60 · r9 · c7 · span 792512–792519
15Section 03, Douglas Coltharp PSUDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t53 · r5 · c4 · span 650770–650772
16Section 03, Patrick Tuer PSUDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t60 · r5 · c7 · span 786066–786073
17Section 03, Douglas Coltharp PSUDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t60 · r6 · c7 · span 787740–787749
18Section 03, Patrick Darby PSUDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t53 · r6 · c4 · span 652264–652266
19Section 03, Mark Tarr PSUDEF 14A2026-04-070000785161-26-000105Section “Grants of Plan-Based Awards During 2025” · grants of plan-based awards table. Filing ↗machine: t53 · r3 · c4 · span 647607–647609
20Section 07, pay ratioDEF 14A2026-04-070000785161-26-000105Section “CEO Pay Ratio”. As printed: 203 : 1. Filing ↗machine: span 1110243–1110248
21Section 08, Greg D. CarmichaelDEF 14A2026-04-070000785161-26-000105Section “Director Compensation”. As printed: 435,211. Filing ↗machine: t24 · r2 · c10 · span 386533–386540
22Section 08, Leslye G. KatzDEF 14A2026-04-070000785161-26-000105Section “Director Compensation”. As printed: 327,609. Filing ↗machine: t24 · r6 · c10 · span 392842–392849
23Section 08, Christopher R. ReidyDEF 14A2026-04-070000785161-26-000105Section “Director Compensation”. As printed: 311,933. Filing ↗machine: t24 · r9 · c10 · span 397635–397642
24Section 08, Nancy M. SchlichtingDEF 14A2026-04-070000785161-26-000105Section “Director Compensation”. As printed: 309,573. Filing ↗machine: t24 · r10 · c10 · span 399165–399172
25Section 08, Joan E. HermanDEF 14A2026-04-070000785161-26-000105Section “Director Compensation”. As printed: 307,609. Filing ↗machine: t24 · r5 · c10 · span 391317–391324
26Section 08, Kevin J. O'ConnorDEF 14A2026-04-070000785161-26-000105Section “Director Compensation”. As printed: 286,080. Filing ↗machine: t24 · r8 · c10 · span 396106–396113
27Section 08, Terrance WilliamsDEF 14A2026-04-070000785161-26-000105Section “Director Compensation”. As printed: 285,211. Filing ↗machine: t24 · r11 · c10 · span 400692–400699
28Section 08, Edward M. Christie IIIDEF 14A2026-04-070000785161-26-000105Section “Director Compensation”. As printed: 277,896. Filing ↗machine: t24 · r3 · c10 · span 388064–388071
29Section 08, Patricia A. MarylandDEF 14A2026-04-070000785161-26-000105Section “Director Compensation”. As printed: 269,867. Filing ↗machine: t24 · r7 · c10 · span 394574–394581
30Section 08, Cain A. HayesDEF 14A2026-04-070000785161-26-000105Section “Director Compensation”. As printed: 0. Filing ↗machine: t24 · r4 · c10 · span 389680–389681
31Section 08, Mark J. TarrDEF 14A2026-04-070000785161-26-000105Section “Director Compensation”. As printed: 0. Filing ↗
32Section 02, Joan E. Herman 2026-04-15Form 42026-04-160000785161-26-000119Insider equity transaction reported since the proxy statement. Filing ↗
33Section 02, Christopher R. Reidy 2026-04-15Form 42026-04-160000785161-26-000113Insider equity transaction reported since the proxy statement. Filing ↗
34Section 02, Christopher R. Reidy 2026-04-15Form 42026-04-160000785161-26-000113Insider equity transaction reported since the proxy statement. Filing ↗
35Section 02, Terrance Williams 2026-04-15Form 42026-04-160000785161-26-000109Insider equity transaction reported since the proxy statement. Filing ↗
36Section 02, Greg D. Carmichael 2026-04-15Form 42026-04-160000785161-26-000125Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Edward M. Christie III 2026-04-15Form 42026-04-160000785161-26-000123Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Kevin J. O'Connor 2026-04-15Form 42026-04-160000785161-26-000115Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Nancy M. Schlichting 2026-04-15Form 42026-04-160000785161-26-000111Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Cain A. Hayes 2026-04-15Form 42026-04-160000785161-26-000121Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Edward M. Christie III 2026-04-15Form 42026-04-160000785161-26-000123Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Leslye G. Katz 2026-04-15Form 42026-04-160000785161-26-000117Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Christopher R. Reidy 2026-05-07Form 42026-05-110000785161-26-000144Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Cain A. Hayes 2026-05-07Form 42026-05-110000785161-26-000142Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Greg D. Carmichael 2026-05-07Form 42026-05-110000785161-26-000140Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Leslye G. Katz 2026-05-07Form 42026-05-110000785161-26-000136Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Joan E. Herman 2026-05-07Form 42026-05-110000785161-26-000134Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Nancy M. Schlichting 2026-05-07Form 42026-05-110000785161-26-000132Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Kevin J. O'Connor 2026-05-07Form 42026-05-110000785161-26-000148Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Edward M. Christie III 2026-05-07Form 42026-05-110000785161-26-000146Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Terrance Williams 2026-05-07Form 42026-05-110000785161-26-000138Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Patrick Tuer 2026-05-11Form 42026-05-120000785161-26-000153Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Douglas Coltharp 2026-05-15Form 42026-05-180000785161-26-000158Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Douglas Coltharp 2026-05-15Form 42026-05-180000785161-26-000158Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Douglas Coltharp 2026-05-15Form 42026-05-180000785161-26-000158Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Douglas Coltharp 2026-05-15Form 42026-05-180000785161-26-000158Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Christopher R. Reidy 2026-07-15Form 42026-07-160000785161-26-000180Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Joan E. Herman 2026-07-15Form 42026-07-160000785161-26-000168Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Leslye G. Katz 2026-07-15Form 42026-07-160000785161-26-000170Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Cain A. Hayes 2026-07-15Form 42026-07-160000785161-26-000166Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Greg D. Carmichael 2026-07-15Form 42026-07-160000785161-26-000164Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Edward M. Christie III 2026-07-15Form 42026-07-160000785161-26-000178Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Edward M. Christie III 2026-07-15Form 42026-07-160000785161-26-000178Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Terrance Williams 2026-07-15Form 42026-07-160000785161-26-000176Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Nancy M. Schlichting 2026-07-15Form 42026-07-160000785161-26-000174Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Kevin J. O'Connor 2026-07-15Form 42026-07-160000785161-26-000172Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Christopher R. Reidy 2026-07-15Form 42026-07-160000785161-26-000180Insider equity transaction reported since the proxy statement. Filing ↗
68Section 06, 2026 voteForm 8-K2026-05-110000785161-26-000151Item 5.07 · say-on-pay result. As reported: 96.52% (votes for as printed: 83,410,829). Filing ↗
69Section 06, 2025 voteForm 8-K2025-05-020000785161-25-000025Item 5.07 · say-on-pay result. As reported: 97.56% (votes for as printed: 87,426,450). Filing ↗
70Section 06, 2024 voteForm 8-K2024-05-060000785161-24-000031Item 5.07 · say-on-pay result. As reported: 97.02% (votes for as printed: 87,432,847). Filing ↗
71Section 01 trend, Δ column (computed)ComputedcomputedΔ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
72Section 03b vehicle mix (computed)ComputedcomputedRSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
73Section 09b board cost (computed)ComputedcomputedCash 1,202,500 + equity 1,485,891 + all other 122,598 = 2,810,989, summed across the director compensation table rows.machine: formula: Σ = 2,810,989
74Labcorp Holdings, Section 10b CEO totalDEF 14A2026-04-100001193125-26-150752CEO total compensation as printed in Labcorp Holdings's own proxy. As printed: 18,339,913. Filing ↗machine: t153 · r3 · c22 · span 3147696–3147706
75DaVita, Section 10b CEO totalDEF 14A2026-04-220000927066-26-000053CEO total compensation as printed in DaVita's own proxy. As printed: 18,210,597. Filing ↗machine: r2 · c45 · span 800715–800725
76Universal Health Services, Section 10b CEO totalDEF 14A2026-04-090001193125-26-148814CEO total compensation as printed in Universal Health Services's own proxy. As printed: 16,148,937. Filing ↗machine: span 1326856–1326866
77Quest Diagnostics, Section 10b CEO totalDEF 14A2026-04-060001140361-26-013356CEO total compensation as printed in Quest Diagnostics's own proxy. As printed: 15,498,479. Filing ↗machine: r2 · c17 · span 699327–699337
78R1 RCM, Section 10b CEO totalDEF 14A2024-04-120001628280-24-015923CEO total compensation as printed in R1 RCM's own proxy. As printed: 14,159,376. Filing ↗machine: span 758069–758079
79Ensign Group, Section 10b CEO totalDEF 14A2026-04-020001125376-26-000014CEO total compensation as printed in Ensign Group's own proxy. As printed: 13,804,700. Filing ↗machine: span 521316–521326
80Chemed, Section 10b CEO totalDEF 14A2026-04-090001562762-26-000052CEO total compensation as printed in Chemed's own proxy. As printed: 12,904,720. Filing ↗machine: t18 · r8 · c8 · span 1091846–1091856
81Alignment Healthcare, Section 10b CEO totalDEF 14A2026-04-240001628280-26-027058CEO total compensation as printed in Alignment Healthcare's own proxy. As printed: 11,278,583. Filing ↗machine: r2 · c21 · span 656828–656838
82AMN Healthcare, Section 10b CEO totalDEF 14A2026-03-180001104659-26-029908CEO total compensation as printed in AMN Healthcare's own proxy. As printed: 10,669,780. Filing ↗machine: t94 · r1 · c42 · span 1287064–1287074
83Encompass Health (subject), Section 10b CEO totalDEF 14A2026-04-070000785161-26-000105CEO total compensation as printed in Encompass Health's own proxy. As printed: 10,297,258. Filing ↗machine: r2 · c48 · span 734470–734480
84Option Care Health, Section 10b CEO totalDEF 14A2026-04-080001140361-26-013825CEO total compensation as printed in Option Care Health's own proxy. As printed: 9,266,330. Filing ↗machine: r2 · c25 · span 1114074–1114083
85Acadia Healthcare, Section 10b CEO totalDEF 14A2026-03-250001140361-26-011130CEO total compensation as printed in Acadia Healthcare's own proxy. As printed: 7,909,463. Filing ↗machine: t159 · r1 · c27 · span 558066–558075
86Surgery Partners, Section 10b CEO totalDEF 14A2026-04-230001638833-26-000039CEO total compensation as printed in Surgery Partners's own proxy. As printed: 6,083,862. Filing ↗machine: r2 · c24 · span 365862–365872
87Agilon health, Section 10b CEO totalDEF 14A2026-04-220001628280-26-026544CEO total compensation as printed in Agilon health's own proxy. As printed: 5,610,878. Filing ↗machine: r5 · c9 · span 1591317–1591326
88Brookdale Senior Living, Section 10b CEO totalDEF 14A2026-04-300001193125-26-197412CEO total compensation as printed in Brookdale Senior Living's own proxy. As printed: 5,307,655. Filing ↗machine: t227 · r4 · c27 · span 1161767–1161776
89Select Medical Holdings, Section 10b CEO totalDEF 14A2026-03-040001104659-26-023205CEO total compensation as printed in Select Medical Holdings's own proxy. As printed: 3,042,527. Filing ↗machine: r13 · c41 · span 384685–384694
90Section 10a, Alignment Healthcare reciprocityDEF 14A0001628280-26-027058Alignment Healthcare's most recent proxy was read; its disclosed peer group does not include Encompass Health. Filing ↗
91Section 10a, Brookdale Senior Living reciprocityDEF 14A0001193125-26-197412Brookdale Senior Living names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
92Section 10a, Ensign Group reciprocityDEF 14A0001125376-26-000014Ensign Group names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
93Section 10a, Quest Diagnostics reciprocityDEF 14A0001140361-26-013356Quest Diagnostics's most recent proxy was read; its disclosed peer group does not include Encompass Health. Filing ↗
94Section 10a, R1 RCM reciprocityDEF 14A0001628280-24-015923R1 RCM's most recent proxy was read; its disclosed peer group does not include Encompass Health. Filing ↗
95Section 10a, DaVita reciprocityDEF 14A0000927066-26-000053DaVita names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
96Section 10a, Surgery Partners reciprocityDEF 14A0001638833-26-000039Surgery Partners names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
97Section 10a, Universal Health Services reciprocityDEF 14A0001193125-26-148814Universal Health Services names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
98Section 10a, Chemed reciprocityDEF 14A0001562762-26-000052Chemed names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
99Section 10a, Agilon health reciprocityDEF 14A0001628280-26-026544Agilon health's most recent proxy was read; its disclosed peer group does not include Encompass Health. Filing ↗
100Section 10a, AMN Healthcare reciprocityDEF 14A0001104659-26-029908AMN Healthcare names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
101Section 10a, Acadia Healthcare reciprocityDEF 14A0001140361-26-011130Acadia Healthcare names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗
102Section 10a, Labcorp Holdings reciprocityDEF 14A0001193125-26-150752Labcorp Holdings's most recent proxy was read; its disclosed peer group does not include Encompass Health. Filing ↗
103Section 10a, Option Care Health reciprocityDEF 14A0001140361-26-013825Option Care Health names Encompass Health in its own disclosed peer group (read from its most recent proxy). Filing ↗